Nagi Bioscience: Nagi Bioscience raises CHF 12.4M to open new markets
Nagi Bioscience, a Swiss life sciences startup developing next-generation laboratory equipment to unlock the full potential of alternatives to animal testing, is thrilled to announce the successful closure of its Series A funding round. The company has secured an oversubscribed 12.4M CHF investment from top-tier venture capital firms across Europe.
Read full article »
Nagi is a Switzerland-based medical technology company that develops laboratory equipment and organism-on-a-chip products for sectors including biopharma and agrochemicals.
Read more